Matinas BioPharma (MTNB) Reports In-Line Q4 EPS
Matinas BioPharma (NYSE: MTNB) reported Q4 EPS of ($0.03), in-line with the analyst estimate of ($0.03).
For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.
Matinas BioPharma (NYSE: MTNB) reported Q4 EPS of ($0.03), in-line with the analyst estimate of ($0.03).
For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.